Interventions on Health and Healthcare Disparities on Non-Communicable and Chronic Diseases in Latin America: Improving Health Outcomes Across the Hemisphere (R01 - Clinical Trial Required)
Funding to improve health outcomes in Latin America & US Latino communities by addressing disparities in non-communicable diseases through innovative interventions.
Funder: National Institutes of Health
Due Dates: June 5, 2025 (New) | July 5, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 5, 2025 (New) | November 5, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 5, 2026 (New) | March 5, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | June 5, 2026 (New) | July 5, 2026 (Renewal/Resubmission/Revision) | September 7, 2026 (AIDS) | October 5, 2026 (New) | November 5, 2026 (Renewal/Resubmission/Revision) | January 7, 2027 (AIDS) | February 5, 2027 (New) | March 5, 2027 (Renewal/Resubmission/Revision) | May 7, 2027 (AIDS)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years. Typical R01 NIH policies apply.
Summary: Supports innovative, interdisciplinary clinical and community-based interventions to reduce health and healthcare disparities in non-communicable and chronic diseases in Latin America and among U.S. Hispanics/Latinos.
Key Information: Applications must include at least one PI or MPI from a Latin America-based institution; majority of research and budget (approx. 70%) should be conducted in Latin America.
Description
This NIH funding opportunity supports innovative, interdisciplinary research projects focused on developing, testing, and evaluating clinical, health services, and/or community-based interventions to address health and healthcare disparities related to non-communicable and chronic diseases (NCDs) in Latin America and among U.S. Hispanics/Latinos. The goal is to improve health outcomes and advance health equity for populations experiencing the highest burden and mortality from NCDs, such as diabetes, cardiovascular disease, cancer, chronic lung disease, chronic kidney disease, and mental/behavioral health conditions.
Projects must be collaborative, with meaningful partnerships between U.S.-based and Latin America-based investigators, and must include at least one PI or MPI from a Latin America-based institution. The majority of research activities and budget should be allocated to Latin America-based institutions.
